Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and Masimo's claims are rejected in court. Apple and medical equipment maker ...

Now I'd like to expand on some of the important initiatives that Michelle had mentioned earlier, which we fully expect will strengthen Masimo's revenue growth and earnings power in 2025 and beyond.

Masimo MASI is set to give its latest quarterly earnings report on Tuesday, 2024-11-05. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an ...

Masimo sells a range of devices used for patient monitoring that feature a proprietary pulse oximetry technology called Signal Extraction Technology (SET). In the latest update on that patent spat ...

Other defendants include Masimo, which makes FDA-approved pulse oximeters; GE Healthcare, which makes patient monitoring systems that include pulse oximetry technology; and CVS and Walgreens, which ...

Masimo alleges that by allying with RTW and ultimately acquiring as much as 19% of Masimo’s outstanding stock he was in breach of laws in the US governing share listed Companies.

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Ty Pendlebury has worked at CNET since 2006. He lives in New York City where he writes about streaming and home audio. Expertise Ty has worked for radio, print, and online publications, and has ...